Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Journal of Bacteriology
|
July 28, 2009
Comparative sequence analysis of Mycobacterium leprae and the new leprosy-causing Mycobacterium lepromatosis
Xiang Y Han, Kurt C Sizer, Erika J Thompson, et al.
American Journal of Clinical Pathology
|
November 21, 2008
A new Mycobacterium species causing diffuse lepromatous leprosy
Xiang Y Han, Yiel-Hea Seo, Kurt C Sizer, et al.
Neurocritical Care
|
October 31, 2007
Critically ill cancer patients are not consistently hypercoagulable after craniotomy
Joseph L Nates, Natarajan Aravindan, Cheryl Hirsch-Ginsberg, et al.
Lancet (London, England)
|
May 16, 2003
Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial
Eric Nisbet-Brown, Nancy F Olivieri, Patricia J Giardina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2005
Phase I and pharmacologic study of PKI166, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies
Ronald Hoekstra, Herlinde Dumez, Ferry A L M Eskens, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Journal of Bacteriology
|
July 28, 2009
Comparative sequence analysis of Mycobacterium leprae and the new leprosy-causing Mycobacterium lepromatosis
Xiang Y Han, Kurt C Sizer, Erika J Thompson, et al.
American Journal of Clinical Pathology
|
November 21, 2008
A new Mycobacterium species causing diffuse lepromatous leprosy
Xiang Y Han, Yiel-Hea Seo, Kurt C Sizer, et al.
Neurocritical Care
|
October 31, 2007
Critically ill cancer patients are not consistently hypercoagulable after craniotomy
Joseph L Nates, Natarajan Aravindan, Cheryl Hirsch-Ginsberg, et al.
Lancet (London, England)
|
May 16, 2003
Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial
Eric Nisbet-Brown, Nancy F Olivieri, Patricia J Giardina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2005
Phase I and pharmacologic study of PKI166, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies
Ronald Hoekstra, Herlinde Dumez, Ferry A L M Eskens, et al.
Page
of 1